PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | +50.0% | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 307 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 307 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | +100.0% | 307 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -64.3% | 307 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | -68.9% | 307 | -82.3% | 0.00% | – |
| Q1 2021 | $45,000 | +200.0% | 1,739 | -23.8% | 0.00% | – |
| Q4 2018 | $15,000 | -77.3% | 2,282 | -64.5% | 0.00% | – |
| Q3 2018 | $66,000 | -25.0% | 6,426 | -51.0% | 0.00% | – |
| Q2 2018 | $88,000 | +87.2% | 13,126 | +141.9% | 0.00% | – |
| Q1 2018 | $47,000 | – | 5,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |